Abstract
Traditional surveillance mechanisms for nonmedical prescription medication use (NPMU) involve substantial lags. Social media-based approaches have been proposed for conducting close-to-real-time surveillance, but such methods typically cannot provide fine-grained statistics about subpopulations. We address this gap by developing methods for automatically characterizing a large Twitter NPMU cohort (n=288,562) in terms of age-group, race, and gender. Our methods achieved 0.88 precision (95%-CI: 0.84-0.92) for age-group, 0.90 (95%-CI: 0.85-0.95) for race, and 0.94 accuracy (95%-CI: 0.92-0.97) for gender. We compared the automatically-derived statistics for the NPMU of tranquilizers, stimulants, and opioids from Twitter to statistics reported in traditional sources (eg., the National Survey on Drug Use and Health). Our estimates were mostly consistent with the traditional sources, except for age-group-related statistics, likely caused by differences in reporting tendencies and representations in the population. Our study demonstrates that subpopulation-specific estimates about NPMU may be automatically derived from Twitter to obtain early insights.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R01DA046619. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Emory University institutional review board (IRB00114235).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated during and/or analysed during the current study are not publicly available due to Twitter API's use terms and privacy concern but are available from the corresponding author on reasonable request.